Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Splenic Neoplasms"" wg kryterium: Temat


Tytuł:
Unusual Case of Splenic Metastasis in Adenosquamous Carcinoma of the Cervix Uteri: Diagnosis and Treatment Considerations.
Autorzy:
Klamminger GG; Department of Gynecology, Obstetrics, and Reproductive Medicine, University Medical School of Saarland, Homburg, Saar, Germany.; Department of Pathology, Saarland University Medical Center, Homburg, Saar, Germany.
Burgard C; Department of Nuclear Medicine, Saarland University, Homburg, Saar, Germany.
Rosar F; Department of Nuclear Medicine, Saarland University, Homburg, Saar, Germany.
Altmeyer K; Department of Diagnostic and Interventional Radiology, Saarland University Medical Center, Homburg, Saar, Germany.
Malinowski M; Department of General, Visceral, Vascular and Pediatric Surgery, Saarland University Medical Center, Homburg, Saar, Germany.
Nigdelis MP; Department of Gynecology, Obstetrics, and Reproductive Medicine, University Medical School of Saarland, Homburg, Saar, Germany.
Stahl PR; Department of Pathology, Saarland University Medical Center, Homburg, Saar, Germany.
Solomayer EF; Department of Gynecology, Obstetrics, and Reproductive Medicine, University Medical School of Saarland, Homburg, Saar, Germany.
Haj Hamoud B; Department of Gynecology, Obstetrics and Reproductive Medicine, University Medical School of Saarland, Homburg, Saar, Germany.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2023 Dec 08; Vol. 24, pp. e941600. Date of Electronic Publication: 2023 Dec 08.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Splenic Neoplasms*/diagnosis
Splenic Neoplasms*/therapy
Carcinoma, Adenosquamous*/diagnosis
Carcinoma, Adenosquamous*/therapy
Female ; Humans ; Adult ; Cervix Uteri/pathology ; Splenectomy/methods ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter real-world study.
Autorzy:
Nie C; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Jinshui District, Zhengzhou City, 450008, Henan Province, China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, 450052, Henan Province, China.; Henan Engineering Research Center of Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.
Xu W; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Jinshui District, Zhengzhou City, 450008, Henan Province, China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, 450052, Henan Province, China.; Henan Engineering Research Center of Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.
Guo Y; Department of Oncology, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan Province, China.
Gao X; Department of Oncology, First Affiliated Hospital of Henan University of Science and Technology, Luoyang, 471003, Henan Province, China.
Lv H; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Jinshui District, Zhengzhou City, 450008, Henan Province, China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, 450052, Henan Province, China.; Henan Engineering Research Center of Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.
Chen B; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Jinshui District, Zhengzhou City, 450008, Henan Province, China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, 450052, Henan Province, China.; Henan Engineering Research Center of Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.
Wang J; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Jinshui District, Zhengzhou City, 450008, Henan Province, China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, 450052, Henan Province, China.; Henan Engineering Research Center of Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.
Liu Y; Department of General Surgery, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, Henan Province, China.
Zhao J; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Jinshui District, Zhengzhou City, 450008, Henan Province, China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, 450052, Henan Province, China.; Henan Engineering Research Center of Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.
Wang S; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Jinshui District, Zhengzhou City, 450008, Henan Province, China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, 450052, Henan Province, China.; Henan Engineering Research Center of Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.
He Y; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Jinshui District, Zhengzhou City, 450008, Henan Province, China.; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, 450052, Henan Province, China.; Henan Engineering Research Center of Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China.
Chen X; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Jinshui District, Zhengzhou City, 450008, Henan Province, China. .; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, 450052, Henan Province, China. .; Henan Engineering Research Center of Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China. .; Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, Henan Province, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Dec 15; Vol. 23 (1), pp. 1239. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Observational Study; Multicenter Study; Journal Article
MeSH Terms:
Stomach Neoplasms*/drug therapy
Splenic Neoplasms*
Drug-Related Side Effects and Adverse Reactions*
Humans ; Immune Checkpoint Inhibitors ; Alopecia
Czasopismo naukowe
Tytuł:
Splenic surprise in a case of renal cell carcinoma: Unusual case or association?
Autorzy:
Agrawal T; Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Epari S; Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Prakash G; Department of Urology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Menon S; Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Pokaż więcej
Źródło:
Journal of postgraduate medicine [J Postgrad Med] 2023 Apr-Jun; Vol. 69 (2), pp. 108-110.
Typ publikacji:
Case Reports
MeSH Terms:
Carcinoma, Renal Cell*/complications
Carcinoma, Renal Cell*/surgery
Splenic Neoplasms*/complications
Splenic Neoplasms*/surgery
Splenic Neoplasms*/diagnosis
Hemangioma*/complications
Hemangioma*/diagnosis
Hemangioma*/pathology
Kidney Neoplasms*
Humans
SCR Disease Name:
Littoral cell angioma of the spleen
Raport
Tytuł:
Littoral cell neoplasm: A least understood splenic tumour.
Autorzy:
Ghosh K; Fmr. Director: National Institute of Immunohaematology, KEM Hospital MS Building, Mumbai, Maharashtra, India.
Pokaż więcej
Źródło:
Journal of postgraduate medicine [J Postgrad Med] 2023 Apr-Jun; Vol. 69 (2), pp. 70-71.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Splenic Neoplasms*/diagnostic imaging
Splenic Neoplasms*/surgery
Splenic Neoplasms*/pathology
Neoplasms*
Humans
Opinia redakcyjna
Tytuł:
Identification of optimal primary tumor resection candidates for metastatic gastric cancer: Nomograms based on propensity score matching.
Autorzy:
Li Z; Department of General Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Zheng H; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Zhao Z; Department of General Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Chen G; Department of General Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Wang Z; Department of General Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Amin B; Department of General Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Zhang N; Department of General Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (12), pp. 13063-13075. Date of Electronic Publication: 2023 Apr 25.
Typ publikacji:
Journal Article
MeSH Terms:
Stomach Neoplasms*/surgery
Splenic Neoplasms*
Humans ; Nomograms ; Propensity Score ; Databases, Factual ; Prognosis ; SEER Program
Czasopismo naukowe
Tytuł:
The inflammatory prognostic index as a potential predictor of prognosis in metastatic gastric cancer.
Autorzy:
Ozveren A; Medical Oncology Department, Internal Medicine, Izmir Private Kent Hospital, Izmir, Turkey. ahmet_.
Erdogan AP; Medical Oncology Department, Internal Medicine, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey.
Ekinci F; Medical Oncology Department, Internal Medicine, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 May 12; Vol. 13 (1), pp. 7755. Date of Electronic Publication: 2023 May 12.
Typ publikacji:
Journal Article
MeSH Terms:
Stomach Neoplasms*/diagnosis
Stomach Neoplasms*/drug therapy
Carcinoma, Non-Small-Cell Lung*
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lung Neoplasms*
Splenic Neoplasms*
Humans ; Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Prognosis ; Disease-Free Survival ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy.
Autorzy:
Faroni E; Department of Veterinary Medical Sciences, Alma Mater Studiorum University of Bologna, Ozzano dell'Emilia, Italy.
Sabattini S; Department of Veterinary Medical Sciences, Alma Mater Studiorum University of Bologna, Ozzano dell'Emilia, Italy.
Guerra D; Department of Veterinary Medical Sciences, Alma Mater Studiorum University of Bologna, Ozzano dell'Emilia, Italy.
Iannuzzi C; Department of Veterinary Medical Sciences, Alma Mater Studiorum University of Bologna, Ozzano dell'Emilia, Italy.
Chalfon C; Department of Veterinary Medical Sciences, Alma Mater Studiorum University of Bologna, Ozzano dell'Emilia, Italy.
Agnoli C; Department of Veterinary Medical Sciences, Alma Mater Studiorum University of Bologna, Ozzano dell'Emilia, Italy.
Stefanello D; Department of Veterinary Medicine and Animal Sciences, University of Milan, Lodi, Italy.
Polton G; North Downs Specialist Referrals, Bletchingley, UK.
Ramos S; North Downs Specialist Referrals, Bletchingley, UK.
Aralla M; Pronto Soccorso Veterinario Laudense, Lodi, Italy.
Ciaccini R; Clinica Veterinaria Ponte Felcino, Perugia, Italy.
Foglia A; Department of Veterinary Medical Sciences, Alma Mater Studiorum University of Bologna, Ozzano dell'Emilia, Italy.
Okonji S; Department of Veterinary Medical Sciences, Alma Mater Studiorum University of Bologna, Ozzano dell'Emilia, Italy.
Marconato L; Department of Veterinary Medical Sciences, Alma Mater Studiorum University of Bologna, Ozzano dell'Emilia, Italy.
Pokaż więcej
Źródło:
Veterinary and comparative oncology [Vet Comp Oncol] 2023 Mar; Vol. 21 (1), pp. 123-130. Date of Electronic Publication: 2023 Jan 21.
Typ publikacji:
Journal Article
MeSH Terms:
Hemangiosarcoma*/drug therapy
Hemangiosarcoma*/surgery
Hemangiosarcoma*/veterinary
Dog Diseases*/drug therapy
Dog Diseases*/surgery
Splenic Neoplasms*/drug therapy
Splenic Neoplasms*/surgery
Splenic Neoplasms*/veterinary
Humans ; Dogs ; Animals ; Splenectomy/veterinary ; Retrospective Studies ; Treatment Outcome ; Chemotherapy, Adjuvant/veterinary
Czasopismo naukowe
Tytuł:
Single cell profiling of γδ hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression.
Autorzy:
Song W; Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, 650500, Yunnan, People's Republic of China.; School of Medicine, Kunming University of Science and Technology, Kunming, 650500, Yunnan, People's Republic of China.; Department of Radiology, The First People's Hospital of Yunnan Province, Kunming, 650032, Yunnan, People's Republic of China.
Zhang H; Department of Hematology, The First People's Hospital of Yunnan Province, Kunming, 650032, Yunnan, People's Republic of China.; Yunnan Province Clinical Center for Hematologic Disease, Kunming, 650032, Yunnan, People's Republic of China.; Yunnan Province Clinical Research Center for Hematologic Disease, Kunming, 650032, Yunnan, People's Republic of China.
Yang F; School of Medicine, Kunming University of Science and Technology, Kunming, 650500, Yunnan, People's Republic of China.
Nakahira K; Department of Pharmacology, Nara Medical University, Kashihara, Nara, 634-8521, Japan.; Division of Pulmonary and Critical Care Medicine, Weill Department of Medicine, Joan and Sanford I, Weill Cornell Medicine, New York, NY, 10065, USA.
Wang C; Innovec Biotherapeutics, Inc., Beijing, 100193, People's Republic of China.
Shi K; Department of Hematology, The First People's Hospital of Yunnan Province, Kunming, 650032, Yunnan, People's Republic of China. .; Yunnan Province Clinical Center for Hematologic Disease, Kunming, 650032, Yunnan, People's Republic of China. .; Yunnan Province Clinical Research Center for Hematologic Disease, Kunming, 650032, Yunnan, People's Republic of China. .
Zhang R; Innovec Biotherapeutics, Inc., Beijing, 100193, People's Republic of China. .
Pokaż więcej
Źródło:
Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2023 Feb; Vol. 46 (1), pp. 211-226. Date of Electronic Publication: 2022 Nov 22.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, T-Cell*/diagnosis
Lymphoma, T-Cell*/genetics
Lymphoma, T-Cell*/pathology
Liver Neoplasms*/metabolism
Splenic Neoplasms*/diagnosis
Splenic Neoplasms*/genetics
Splenic Neoplasms*/pathology
Humans ; Receptors, Antigen, T-Cell, gamma-delta/analysis ; Receptors, Antigen, T-Cell, gamma-delta/genetics ; Receptors, Antigen, T-Cell, gamma-delta/metabolism ; Disease Progression ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcoma.
Autorzy:
Musser ML; Veterinary Clinical Sciences, Iowa State University, Ames, Iowa, United States of America.
Coto GM; Veterinary Clinical Sciences, Iowa State University, Ames, Iowa, United States of America.
Lingnan Y; Biomedical Sciences, Iowa State University, Ames, Iowa, United States of America.; SMART Pharmacology, Iowa State University, Ames, Iowa, United States of America.
Mochel JP; Biomedical Sciences, Iowa State University, Ames, Iowa, United States of America.; SMART Pharmacology, Iowa State University, Ames, Iowa, United States of America.
Johannes CM; Veterinary Clinical Sciences, Iowa State University, Ames, Iowa, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Dec 22; Vol. 17 (12), pp. e0279594. Date of Electronic Publication: 2022 Dec 22 (Print Publication: 2022).
Typ publikacji:
Clinical Trial, Veterinary; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Dog Diseases*/drug therapy
Hemangiosarcoma*/drug therapy
Hemangiosarcoma*/veterinary
Splenic Neoplasms*/veterinary
Animals ; Dogs ; Doxorubicin/adverse effects ; Immunotherapy ; Prospective Studies
Czasopismo naukowe
Tytuł:
Polar/villous lymphocytes in peripheral blood and exclusively intrasinusoidal lymphoma infiltrate in bone marrow: A clue to splenic diffuse red pulp lymphoma.
Autorzy:
Parmley M; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Gagan J; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Imam M; Florida Cancer Specialists, Orlando, Florida, USA.
Chen W; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2022 Dec; Vol. 44 (6), pp. 970-971. Date of Electronic Publication: 2022 Mar 10.
Typ publikacji:
Case Reports
MeSH Terms:
Lymphoma*/diagnosis
Lymphoma*/pathology
Splenic Neoplasms*/diagnosis
Humans ; Bone Marrow/pathology ; Lymphocytes/pathology
Raport
Tytuł:
Evaluation of the anti-tumour activity of Coriolus versicolor polysaccharopeptide (I'm-Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma.
Autorzy:
Gedney A; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Salah P; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Mahoney JA; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Krick E; Mount Laurel Animal Hospital, Mount Laurel, New Jersey, USA.
Martins R; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Scavello H; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Lenz JA; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Atherton MJ; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło:
Veterinary and comparative oncology [Vet Comp Oncol] 2022 Sep; Vol. 20 (3), pp. 688-696. Date of Electronic Publication: 2022 Apr 25.
Typ publikacji:
Journal Article; Randomized Controlled Trial, Veterinary
MeSH Terms:
Dog Diseases*/drug therapy
Hemangiosarcoma*/drug therapy
Hemangiosarcoma*/veterinary
Splenic Neoplasms*/drug therapy
Splenic Neoplasms*/veterinary
Animals ; Dogs ; Doxorubicin/therapeutic use ; Drugs, Chinese Herbal ; Female ; Male ; Pilot Projects ; Polyporaceae ; Prospective Studies ; Proteoglycans
SCR Organism:
Trametes versicolor
Czasopismo naukowe
Tytuł:
Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients.
Autorzy:
Wong S; Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
Ehrhart EJ; Charles River Laboratories, Wilmington, MA, United States of America.
Stewart S; Ethos Discovery, San Diego, CA, United States of America.; Ethos Veterinary Health, Woburn, MA, United States of America.
Zismann V; Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
Cawley J; Charles River Laboratories, Wilmington, MA, United States of America.; Ethos Discovery, San Diego, CA, United States of America.; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio, United States of America.
Halperin R; Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
Briones N; Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
Richter K; Ethos Discovery, San Diego, CA, United States of America.; Ethos Veterinary Health, Woburn, MA, United States of America.
Sivaprakasam K; Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
Perdigones N; Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
Contente-Cuomo T; Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
Facista S; Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
Trent JM; Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
Murtaza M; Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
Khanna C; Ethos Discovery, San Diego, CA, United States of America.; Ethos Veterinary Health, Woburn, MA, United States of America.
Hendricks WPD; Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jul 22; Vol. 17 (7), pp. e0264986. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Dog Diseases*/genetics
Hemangiosarcoma*/genetics
Hemangiosarcoma*/veterinary
Splenic Neoplasms*/genetics
Splenic Neoplasms*/veterinary
Animals ; Dogs ; Genomics ; Humans ; Mutation ; Prospective Studies ; Exome Sequencing
Czasopismo naukowe
Tytuł:
Hepatosplenic T-cell lymphoma diagnosed using flow cytometry. A single-center study of 12 cases from North India.
Autorzy:
Rahman K; Department of Hematology, SGPGI, Lucknow, Uttar Pradesh, India.
Gupta T; Department of Hematology, SGPGI, Lucknow, Uttar Pradesh, India.
Gupta R; Department of Hematology, SGPGI, Lucknow, Uttar Pradesh, India.
Singh L; Department of Hematology, SGPGI, Lucknow, Uttar Pradesh, India.
Chandra D; Department of Hematology, SGPGI, Lucknow, Uttar Pradesh, India.
Sarkar MK; Department of Hematology, SGPGI, Lucknow, Uttar Pradesh, India.
Singh MK; Department of Hematology, SGPGI, Lucknow, Uttar Pradesh, India.
Kumar S; Department of Hematology, SGPGI, Lucknow, Uttar Pradesh, India.
Nityanand S; Department of Hematology, SGPGI, Lucknow, Uttar Pradesh, India.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2022 Jul-Sep; Vol. 18 (4), pp. 1093-1097.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Neoplasms*/diagnosis
Liver Neoplasms*/epidemiology
Liver Neoplasms*/genetics
Lymphoma, T-Cell*/diagnosis
Lymphoma, T-Cell*/epidemiology
Splenic Neoplasms*/diagnosis
Splenic Neoplasms*/epidemiology
Flow Cytometry ; Humans ; Leukocytosis ; Receptors, Antigen, T-Cell, gamma-delta/analysis ; Receptors, Antigen, T-Cell, gamma-delta/genetics ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Calorie restriction has no effect on bone marrow tumour burden in a Vk*MYC transplant model of multiple myeloma.
Autorzy:
Bradey AL; Myeloma Research Laboratory, Faculty of Health and Medical Sciences, School of Biomedicine, University of Adelaide, Adelaide, Australia.; Precision Cancer Medicine Theme, Solid Tumour Program, South Australian Health and Medical Research Institute, Adelaide, Australia.
Fitter S; Myeloma Research Laboratory, Faculty of Health and Medical Sciences, School of Biomedicine, University of Adelaide, Adelaide, Australia.; Precision Cancer Medicine Theme, Solid Tumour Program, South Australian Health and Medical Research Institute, Adelaide, Australia.
Duggan J; Myeloma Research Laboratory, Faculty of Health and Medical Sciences, School of Biomedicine, University of Adelaide, Adelaide, Australia.; Precision Cancer Medicine Theme, Solid Tumour Program, South Australian Health and Medical Research Institute, Adelaide, Australia.
Wilczek V; Myeloma Research Laboratory, Faculty of Health and Medical Sciences, School of Biomedicine, University of Adelaide, Adelaide, Australia.; Precision Cancer Medicine Theme, Solid Tumour Program, South Australian Health and Medical Research Institute, Adelaide, Australia.
Williams CMD; Myeloma Research Laboratory, Faculty of Health and Medical Sciences, School of Biomedicine, University of Adelaide, Adelaide, Australia.; Precision Cancer Medicine Theme, Solid Tumour Program, South Australian Health and Medical Research Institute, Adelaide, Australia.
Cheney EA; Myeloma Research Laboratory, Faculty of Health and Medical Sciences, School of Biomedicine, University of Adelaide, Adelaide, Australia.; Precision Cancer Medicine Theme, Solid Tumour Program, South Australian Health and Medical Research Institute, Adelaide, Australia.
Noll JE; Myeloma Research Laboratory, Faculty of Health and Medical Sciences, School of Biomedicine, University of Adelaide, Adelaide, Australia.; Precision Cancer Medicine Theme, Solid Tumour Program, South Australian Health and Medical Research Institute, Adelaide, Australia.
Tangseefa P; Myeloma Research Laboratory, Faculty of Health and Medical Sciences, School of Biomedicine, University of Adelaide, Adelaide, Australia.; Precision Cancer Medicine Theme, Solid Tumour Program, South Australian Health and Medical Research Institute, Adelaide, Australia.
Panagopoulos V; Myeloma Research Laboratory, Faculty of Health and Medical Sciences, School of Biomedicine, University of Adelaide, Adelaide, Australia. .; Precision Cancer Medicine Theme, Solid Tumour Program, South Australian Health and Medical Research Institute, Adelaide, Australia. .
Zannettino ACW; Myeloma Research Laboratory, Faculty of Health and Medical Sciences, School of Biomedicine, University of Adelaide, Adelaide, Australia.; Precision Cancer Medicine Theme, Solid Tumour Program, South Australian Health and Medical Research Institute, Adelaide, Australia.; Department of Haematology, Royal Adelaide Hospital, Adelaide, Australia.; Central Adelaide Local Health Network, Adelaide, Australia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jul 30; Vol. 12 (1), pp. 13128. Date of Electronic Publication: 2022 Jul 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bone Marrow Neoplasms*
Multiple Myeloma*/complications
Noncommunicable Diseases*
Splenic Neoplasms*
Animals ; Caloric Restriction/methods ; Diet, High-Fat ; Mice ; Mice, Inbred C57BL ; Obesity/metabolism ; Paraproteins
Czasopismo naukowe
Tytuł:
Refractory Splenic Marginal Zone Lymphoma Responsive to Combination Venetoclax and Bortezomib (Velcade) (V ) Therapy.
Autorzy:
Roche KC; Department of Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.
DeRosa PA; Department of Pathology, The University of Maryland Medical Center, Baltimore, MD 21201, USA.
Liu ML; Department of Pathology, George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.; Department of Pathology, Veterans Health Administration Medical Center, Washington, DC 20422, USA.
Nava VE; Department of Pathology, George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.; Department of Pathology, Veterans Health Administration Medical Center, Washington, DC 20422, USA.
Aggarwal A; Department of Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.; Department of Pathology, Veterans Health Administration Medical Center, Washington, DC 20422, USA.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Jun 06; Vol. 29 (6), pp. 4117-4124. Date of Electronic Publication: 2022 Jun 06.
Typ publikacji:
Case Reports
MeSH Terms:
Leukemia, Lymphocytic, Chronic, B-Cell*
Lymphoma*
Splenic Neoplasms*/drug therapy
Splenic Neoplasms*/pathology
Bortezomib/therapeutic use ; Bridged Bicyclo Compounds, Heterocyclic ; Humans ; Sulfonamides
Raport
Tytuł:
Feasibility of circulating tumor DNA analysis in dogs with naturally occurring malignant and benign splenic lesions.
Autorzy:
Favaro PF; Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.; Department of Surgery and Center for Human Genomics and Precision Medicine, University of Wisconsin-Madison, Madison, WI, USA.
Stewart SD; Ethos Veterinary Health, Woburn, MA, USA.; Ethos Discovery, San Diego, CA, USA.
McDonald BR; Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.; Department of Surgery and Center for Human Genomics and Precision Medicine, University of Wisconsin-Madison, Madison, WI, USA.
Cawley J; Ethos Veterinary Health, Woburn, MA, USA.; Ethos Discovery, San Diego, CA, USA.
Contente-Cuomo T; Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.
Wong S; Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.
Hendricks WPD; Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.
Trent JM; Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.
Khanna C; Ethos Veterinary Health, Woburn, MA, USA. .; Ethos Discovery, San Diego, CA, USA. .
Murtaza M; Translational Genomics Research Institute (TGen), Phoenix, AZ, USA. .; Department of Surgery and Center for Human Genomics and Precision Medicine, University of Wisconsin-Madison, Madison, WI, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Apr 15; Vol. 12 (1), pp. 6337. Date of Electronic Publication: 2022 Apr 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Circulating Tumor DNA*/genetics
Hemangiosarcoma*/genetics
Hemangiosarcoma*/veterinary
Splenic Neoplasms*/genetics
Splenic Neoplasms*/veterinary
Animals ; Biomarkers, Tumor/genetics ; Disease Progression ; Dogs ; Feasibility Studies ; Mutation
Czasopismo naukowe
Tytuł:
Laparoscopic versus open surgery for locally advanced and metastatic gastric cancer complicated with bleeding and/or stenosis: short- and long-term outcomes.
Autorzy:
Khorobrykh TV; Department of Faculty Surgery №2, I.M.Sechenov First Moscow State Medical University, Moscow, Russia.
Abdulkhakimov NM; Department of Faculty Surgery №2, I.M.Sechenov First Moscow State Medical University, Moscow, Russia.
Agadzhanov VG; Department of Faculty Surgery №2, I.M.Sechenov First Moscow State Medical University, Moscow, Russia.
Aghayan DL; The Intervention Centre, Oslo University Hospital, Oslo, Norway.; Department of Surgery N1, Yerevan State Medical University after M. Heratsi, Yerevan, Armenia.
Kazaryan AM; Department of Faculty Surgery №2, I.M.Sechenov First Moscow State Medical University, Moscow, Russia. .; The Intervention Centre, Oslo University Hospital, Oslo, Norway. .; Department of Surgery N1, Yerevan State Medical University after M. Heratsi, Yerevan, Armenia. .; Department of Gastrointestinal Surgery, Østfold Hospital Trust, Grålum, Norway. .; Department of Surgery, Helse Fonna Hospital Trust, Odda, Norway. .; Institute for Clinical Medicine, Medical Faculty, University of Oslo, Oslo, Norway. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2022 Jun 25; Vol. 20 (1), pp. 216. Date of Electronic Publication: 2022 Jun 25.
Typ publikacji:
Journal Article
MeSH Terms:
Laparoscopy*
Splenic Neoplasms*/surgery
Stomach Neoplasms*/complications
Stomach Neoplasms*/pathology
Stomach Neoplasms*/surgery
Blood Loss, Surgical ; Constriction, Pathologic/surgery ; Gastrectomy/methods ; Humans ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Spleen metastases secondary to gastric neuroendocrine carcinoma: case report.
Autorzy:
Nasr S; Faculty of Medicine of Tunis, Tunis, Tunisia.
Khsiba A; Faculty of Medicine of Tunis, Tunis, Tunisia.
Mahmoudi M; Faculty of Medicine of Tunis, Tunis, Tunisia.
Mohamed AB; Faculty of Medicine of Tunis, Tunis, Tunisia.
Bouasida M; Faculty of Medicine of Tunis, Tunis, Tunisia.
Hamzaoui L; Faculty of Medicine of Tunis, Tunis, Tunisia.
Pokaż więcej
Źródło:
The Pan African medical journal [Pan Afr Med J] 2022 Jun 16; Vol. 42, pp. 131. Date of Electronic Publication: 2022 Jun 16 (Print Publication: 2022).
Typ publikacji:
Case Reports
MeSH Terms:
Carcinoma, Neuroendocrine*/diagnosis
Carcinoma, Neuroendocrine*/pathology
Neuroendocrine Tumors*/diagnosis
Neuroendocrine Tumors*/pathology
Splenic Neoplasms*/diagnosis
Stomach Neoplasms*/diagnosis
Stomach Neoplasms*/pathology
Humans ; Male ; Middle Aged
Raport
Tytuł:
Prognostic value of sternal lymphadenopathy on malignancy and survival in dogs undergoing splenectomy.
Autorzy:
Kelsey J; Surgery and Radiology Department, VCA Animal Specialty and Emergency Center, Los Angeles, California, USA.
Balfour R; Surgery and Radiology Department, VCA Animal Specialty and Emergency Center, Los Angeles, California, USA.
Szabo D; Surgery and Radiology Department, VCA Animal Specialty and Emergency Center, Los Angeles, California, USA.
Kass PH; Surgery and Radiology Department, VCA Animal Specialty and Emergency Center, Los Angeles, California, USA.; Davis School of Veterinary Medicine, University of California, Davis, California, USA.
Pokaż więcej
Źródło:
Veterinary and comparative oncology [Vet Comp Oncol] 2022 Mar; Vol. 20 (1), pp. 1-7. Date of Electronic Publication: 2021 Apr 28.
Typ publikacji:
Journal Article
MeSH Terms:
Dog Diseases*/diagnosis
Hemangiosarcoma*/surgery
Hemangiosarcoma*/veterinary
Lymphadenopathy*/veterinary
Splenic Neoplasms*/pathology
Splenic Neoplasms*/veterinary
Animals ; Dogs ; Hemoperitoneum/veterinary ; Prognosis ; Retrospective Studies ; Splenectomy/veterinary
Czasopismo naukowe
Tytuł:
NOTCH signaling in the pathogenesis of splenic marginal zone lymphoma-opportunities for therapy.
Autorzy:
Alderuccio JP; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Lossos IS; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.; Department of Molecular and Cellular Pharmacology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Feb; Vol. 63 (2), pp. 279-290. Date of Electronic Publication: 2021 Sep 29.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Leukemia, Lymphocytic, Chronic, B-Cell*
Lymphoma*
Lymphoma, B-Cell, Marginal Zone*/diagnosis
Lymphoma, B-Cell, Marginal Zone*/drug therapy
Lymphoma, B-Cell, Marginal Zone*/etiology
Splenic Neoplasms*/diagnosis
Splenic Neoplasms*/drug therapy
Splenic Neoplasms*/etiology
Humans ; Mutation ; Signal Transduction
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies